Biosimilars and Patients: Addressing Safety, Cost, Anxiety
Physicians can respond to pushback from patients on switching to a biosimilar by offering resources and discussing options for both biosimilar and reference drugs.
Source: medscape.com
Stay updated with breaking news from Biosimilars Specialist Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Physicians can respond to pushback from patients on switching to a biosimilar by offering resources and discussing options for both biosimilar and reference drugs.